Synsam AB (publ) (SYNSAM.ST)
SEK 46.3
(0.76%)
SEK 46.3
(0.76%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 3.25 Billion SEK | -4.18% |
| 2022 | 3.39 Billion SEK | 8.67% |
| 2021 | 3.12 Billion SEK | -55.66% |
| 2020 | 7.05 Billion SEK | 3.72% |
| 2019 | 6.79 Billion SEK | 7.67% |
| 2018 | 6.31 Billion SEK | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 3.33 Billion SEK | 0.3% |
| 2024 Q1 | 3.32 Billion SEK | 2.03% |
| 2023 Q4 | 3.25 Billion SEK | -3.81% |
| 2023 Q2 | 3.44 Billion SEK | 1.03% |
| 2023 Q1 | 3.41 Billion SEK | 0.47% |
| 2023 Q3 | 3.38 Billion SEK | -1.86% |
| 2023 FY | 3.25 Billion SEK | -4.18% |
| 2022 Q4 | 3.39 Billion SEK | 1.16% |
| 2022 FY | 3.39 Billion SEK | 8.67% |
| 2022 Q3 | 3.35 Billion SEK | 0.63% |
| 2022 Q2 | 3.33 Billion SEK | 5.0% |
| 2022 Q1 | 3.17 Billion SEK | 1.66% |
| 2021 Q1 | 7.17 Billion SEK | 4.99% |
| 2021 Q4 | 3.12 Billion SEK | -56.83% |
| 2021 Q3 | 7.24 Billion SEK | 3.07% |
| 2021 Q2 | 7.02 Billion SEK | -2.02% |
| 2021 FY | 3.12 Billion SEK | -55.66% |
| 2020 FY | 7.05 Billion SEK | 3.72% |
| 2020 Q4 | 6.82 Billion SEK | 0.0% |
| 2020 Q1 | - SEK | 0.0% |
| 2019 FY | 6.79 Billion SEK | 7.67% |
| 2018 FY | 6.31 Billion SEK | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| AddLife AB (publ) | 5.28 Billion SEK | 38.457% |
| Biotage AB (publ) | 150 Million SEK | -2070.0% |
| Bonesupport Holding AB (publ) | 17.48 Million SEK | -18517.021% |
| Doxa AB (publ) | 9.7 Million SEK | -33456.701% |
| Elekta AB (publ) | 7.24 Billion SEK | 55.091% |
| iZafe Group AB (publ) | 3.17 Million SEK | -102419.685% |
| Ortivus AB (publ) | 5.48 Million SEK | -59286.973% |
| Ortivus AB (publ) | 5.48 Million SEK | -59286.973% |
| Q-linea AB (publ) | 20.56 Million SEK | -15727.863% |
| S2Medical AB (publ) | - SEK | -Infinity% |